Report 32: Age groups that sustain resurging COVID-19 epidemics in the United States
Mélodie Monod, View ORCID ProfileAlexandra Blenkinsop, Xiaoyue Xi, Daniel Hebert, Sivan Bershan, Simon Tietze, Valerie C Bradley, Yu Chen, Helen Coupland, Sarah Filippi, Jonathan Ish-Horowicz, Martin McManus, Thomas Mellan, View ORCID ProfileAxel Gandy, Michael Hutchinson, View ORCID ProfileH Juliette T Unwin, Michaela A C Vollmer, Sebastian Weber, Harrison Zhu, Anne Bezancon, Neil M Ferguson, View ORCID ProfileSwapnil Mishra, Seth Flaxman, Samir Bhatt, View ORCID ProfileOliver Ratmann on behalf of the Imperial College COVID-19 Response Team
doi: https://doi.org/10.1101/2020.09.18.20197376
Mélodie Monod
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Alexandra Blenkinsop
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Xiaoyue Xi
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Daniel Hebert
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Sivan Bershan
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Simon Tietze
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Valerie C Bradley
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Yu Chen
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Helen Coupland
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Sarah Filippi
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Jonathan Ish-Horowicz
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Martin McManus
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Thomas Mellan
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Axel Gandy
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Michael Hutchinson
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
H Juliette T Unwin
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Michaela A C Vollmer
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Sebastian Weber
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Harrison Zhu
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Anne Bezancon
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Neil M Ferguson
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Swapnil Mishra
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Seth Flaxman
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Samir Bhatt
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Oliver Ratmann
1Department of Mathematics, Imperial College London
2Foursquare Inc
3Emodo Inc
4Department of Infectious Disease Epidemiology, Imperial College London
5WHO Collaborating Centre for Infectious Disease Modelling
6MRC Centre for Global Infectious Disease Analytics
7Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London
8Novartis Pharma AG, Basel, Switzerland
9Department of Statistics, University of Oxford
Article usage
Posted September 22, 2020.
Report 32: Age groups that sustain resurging COVID-19 epidemics in the United States
Mélodie Monod, Alexandra Blenkinsop, Xiaoyue Xi, Daniel Hebert, Sivan Bershan, Simon Tietze, Valerie C Bradley, Yu Chen, Helen Coupland, Sarah Filippi, Jonathan Ish-Horowicz, Martin McManus, Thomas Mellan, Axel Gandy, Michael Hutchinson, H Juliette T Unwin, Michaela A C Vollmer, Sebastian Weber, Harrison Zhu, Anne Bezancon, Neil M Ferguson, Swapnil Mishra, Seth Flaxman, Samir Bhatt, Oliver Ratmann
medRxiv 2020.09.18.20197376; doi: https://doi.org/10.1101/2020.09.18.20197376
Report 32: Age groups that sustain resurging COVID-19 epidemics in the United States
Mélodie Monod, Alexandra Blenkinsop, Xiaoyue Xi, Daniel Hebert, Sivan Bershan, Simon Tietze, Valerie C Bradley, Yu Chen, Helen Coupland, Sarah Filippi, Jonathan Ish-Horowicz, Martin McManus, Thomas Mellan, Axel Gandy, Michael Hutchinson, H Juliette T Unwin, Michaela A C Vollmer, Sebastian Weber, Harrison Zhu, Anne Bezancon, Neil M Ferguson, Swapnil Mishra, Seth Flaxman, Samir Bhatt, Oliver Ratmann
medRxiv 2020.09.18.20197376; doi: https://doi.org/10.1101/2020.09.18.20197376
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)